The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Mar. 12, 2014
Applicant:
Kci Licensing, Inc., San Antonio, TX (US);
Inventors:
Braden King-Fung Leung, San Antonio, TX (US);
Ona Whelove, San Antonio, TX (US);
Chester R. Edlund, San Antonio, TX (US);
John R. Harper, Boerne, TX (US);
Assignee:
KCI Licensing, Inc., San Antonio, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/39 (2006.01); A61L 26/00 (2006.01); A61K 45/06 (2006.01); A61M 1/00 (2006.01); A61M 5/142 (2006.01); A61F 13/00 (2006.01); A61K 33/38 (2006.01); A61K 38/01 (2006.01); A61K 31/14 (2006.01); A61K 33/30 (2006.01); A61K 33/34 (2006.01); A61K 31/201 (2006.01); A61K 36/54 (2006.01); A61K 31/155 (2006.01); A61K 31/785 (2006.01); A61K 33/00 (2006.01); A61K 31/7036 (2006.01); A61K 35/76 (2015.01); A61K 36/61 (2006.01); A61K 33/04 (2006.01); A61K 36/232 (2006.01); A61K 36/886 (2006.01); A61K 9/00 (2006.01); A61L 15/32 (2006.01); A61K 31/085 (2006.01); A61K 38/40 (2006.01); A61L 15/42 (2006.01); A61L 15/46 (2006.01);
U.S. Cl.
CPC ...
A61K 38/39 (2013.01); A61F 13/00063 (2013.01); A61F 13/00068 (2013.01); A61K 9/0014 (2013.01); A61K 31/085 (2013.01); A61K 31/14 (2013.01); A61K 31/155 (2013.01); A61K 31/201 (2013.01); A61K 31/7036 (2013.01); A61K 31/785 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 33/30 (2013.01); A61K 33/34 (2013.01); A61K 33/38 (2013.01); A61K 35/76 (2013.01); A61K 36/232 (2013.01); A61K 36/54 (2013.01); A61K 36/61 (2013.01); A61K 36/886 (2013.01); A61K 38/014 (2013.01); A61K 38/40 (2013.01); A61K 45/06 (2013.01); A61L 15/325 (2013.01); A61L 15/425 (2013.01); A61L 15/46 (2013.01); A61L 26/0033 (2013.01); A61L 26/0066 (2013.01); A61M 1/0088 (2013.01); A61M 5/142 (2013.01);
Abstract
Provided herein are biologically active solution compositions comprising one or more sacrificial proteolytic enzyme substrates, one or more preservatives, and one or more antimicrobial agents and methods of using the solution compositions to treat tissue sites, in particular chronic wounds. The compositions may be used in conjunction with negative pressure wound therapy to treat tissue sites.